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4Figure S1. Experimental (A) and theoretical (B) FT-IR spectra of 1.
Scheme S1. Numbering of atoms of Hqasesc in 1, used in NMR.
5Figure S2. 1H NMR spectrum of 1 in DMSO-d6.
Figure S3. 13C NMR spectrum of 1 in DMSO-d6.
6Figure S4. COSY spectrum of 1.
Figure S5. NOESY spectrum of 1.
7Figure S6. 1H‒13C HSQC spectrum of 1.
Figure S7. 1H‒13C HMBC spectrum of 1.
8Figure S8. Superimposed 1H (A) and 13C NMR spectra (B) of Hqasesc (cyan) and 1 (red).
9Figure S9. Superimposed 1H NMR spectra of freshly prepared sample of 1 (cyan) and 
sample after 24 h (red).
Figure S10. Cyclic voltammograms of Hqasesc (cyan), 1 (blue), and 1 with addition of zinc 
perchlorate (red) in anhydrous DMSO containing 0.10 M 
[n-Bu4N][PF6] at a scan rate of 100 mV s-1 using a glassy carbon working electrode.
10
Figure S11. (A) UV-Vis spectra of Hqasesc in pH range 1.65‒5.17 used for pKa1 
determination (t = 25 °C); The spectra were recorded at following pH values: 1.65, 1.83, 
2.06, 2.46, 2.71, 3.03, 3.17, 3.33, 3.67, 3.84, 4.13, 4.30, 5.17; Spectra of pure H2A+, and HA 
forms and isosbestic points are indicated. (B) Determination of Ka1 at 341 nm according to 
equation 2; slope = 4.01 × 10‒4, intercept = 0.315, r2 = 0.993.
Figure S12. (A) UV/Vis Spectra of Hqasesc in pH range 5.17‒11.91 used for pKa2 
determination (t = 25 °C); The spectra were recorded at following pH values: 5.17, 6.56, 
7.01, 7.32, 7.65, 8.06, 8.82, 11.91; Spectra of pure HA and A– forms and isosbestic points are 
indicated. (B) Determination of Ka2 at 365 nm according to equation 3a; slope = ‒8.34 × 10‒8, 
intercept = 4.97 × 10‒8, r2 = 0.995.
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Figure S13. Packing diagram in the crystal structure of Hqasesc.
Figure S14. Packing diagram in the crystal structure of 1.
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Table S1. Hydrogen bonding geometry (Å, °) in Hqasesc and 1.
D–H···A D–H H···A D···A D–H···A
Hqasesc
N4–H4A···N1i 0.77(4) 2.45(4) 3.198(3) 163(3)
N3–H3···Se1ii 0.86(3) 2.68(3) 3.533(2) 172(3)
1
N3–H3···O3 0.866(18) 2.39(3) 3.082(4) 137(3)
N4–H4A···O3 0.86 2.58 3.259(5) 137.1
N4–H4A···O9Ai 0.86 2.49 3.041(5) 122.7
N4–H4A···O9Bi 0.86 2.49 2.970(8) 116.3
N4–H4B···O4i 0.86 2.48 3.164(5) 137.3
N3A–H3A···O9Aii 0.846(18) 2.01(2) 2.802(4) 155(4)
N3A–H3A···O9Bii 0.846(18) 1.97(2) 2.795(7) 163(4)
N4A–H4C···O7iii 0.86 2.34 3.017(5) 135.4
N4A–H4C···O9Aii 0.86 2.35 3.085(5) 143.4
N4A–H4D···Se1iii 0.86 2.67 3.447(3) 150.1
O9A–H9A1···O7iv 0.82 2.19 2.955(8) 156.1
O9B–H9B···O1 0.82 2.08 2.818(11) 150.1
Symmetry codes for Hqasesc: (i) x − 1/2, −y + 3/2, z − 1/2; (ii) –x + 1, −y + 2, −z + 1. 
Symmetry codes for 1: (i) –x + 1, y + 1/2, −z + 1/2; (ii) −x, y + 1/2, −z + 1/2; (iii) −x, y 
−1/2, −z + 1/2; (iv) x, y − 1, z.
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Figure S15. ED50 values for Hqasesc, 1 and CDDP on THP-1 and AsPC-1 cells. THP-1 and 
AsPC-1 cells were treated with Hqasesc, 1 and CDDP applied in a range of six concentrations 
for 24 h, and afterwards stained with Annexin-V and PI. Percentages of all Annexin-V 
labeled cells for each concentration of investigated compounds were calculated as a 
proportion of the maximal apoptotic response normalized as 100%. Such scaled apoptotic 
outcomes were plotted against concentrations and ED50 concentration was calculated using 
asymmetric sigmoidal curve five-parameter logistic equation (GraphPad Prism 6 software).
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Figure S16. Stern-Volmer plot of F0/F vs. [Q] at three different temperatures, where F0 and F 
represents HSA fluorescence intensities in absence (F0) and in presence of the quencher (F), 
and [Q] is the concentration of the quencher (1).
Figure S17. Modified Stern-Volmer plot for binding of 1 to HSA at three temperatures.
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Figure S18. The plot of lnKa (Ka given in M-1) vs. 1/T for the interaction of 1 with HSA.
Figure S19.  Double-log plot for determination of binding constants Kb, and the number of
binding sites n at three temperatures; Concentration of quencher, [Q] is given in M.
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Figure S20.  Spectral overlap of complex 1 absorption (curve A, dashed line) with HSA 
fluorescence emission (F, solid line); c(HSA) = c(1) = 5 × 10‒7 M; T = 298 K.
Figure S21.  All conformations of complex 1 in the DNA duplex of sequence 
d(CGCGAATTCGCG)2 from PDB IDs 3U2NS1 (A)  and 4U8AS2 (B).
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Figure S22. Structure  of  HSA  (PDB  ID  1BJ5S3)  and  the  location  of  complex 1 binding 
site.
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Table S2. Interactions of HSA binding site atoms with 1.
Residue (atom) Interaction type Distance
Glu 354 (OE1) Hydrogen bond/electrostatic 2.089
Glu 354 (OE1) Hydrogen bond/ electrostatic 2.726
Phe 206 (O) Hydrogen bond 1.987
Ala 210 Hydrophobic CH‒π 4.639
Ala 210 Hydrophobic CH‒π 3.725
Leu 347 Hydrophobic CH‒π 4.968
Lys 351 Hydrophobic CH‒π 5.074
Leu 481 Hydrophobic CH‒π 4.903
Val 482 Hydrophobic CH‒π 4.814
Val 482 Hydrophobic CH‒π 5.247
Phe 206 Hydrophobic / π‒π 4.603
Arg 209 (NH1) ‒ Se Hydrogen bond 2.749
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